{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/trofinetide.json","peptide":{"slug":"trofinetide","name":"Trofinetide","url":"https://peptidescanner.com/peptides/trofinetide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":27,"entries":[{"objectId":"story:clinicaltrials-gov-nct02715115-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02715115","domain":"Clinical trials","dateInSource":"2020-08-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02715115-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct02715115-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#clinicaltrials-gov-nct02715115-trofinetide-v1","contentSha256":"4764a114315357fbf4b2ffb5b6ea7842fcf2af3c1dfa1ef904503e0fe843550e"},{"objectId":"story:clinicaltrials-gov-nct04181723-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04181723","domain":"Clinical trials","dateInSource":"2024-04-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04181723-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct04181723-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#clinicaltrials-gov-nct04181723-trofinetide-v1","contentSha256":"3eee8dda6358bb47fac172c5176e31c6dd5fd480b34c97d8ebde0aed1475742f"},{"objectId":"story:clinicaltrials-gov-nct04279314-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04279314","domain":"Clinical trials","dateInSource":"2024-04-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04279314-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct04279314-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#clinicaltrials-gov-nct04279314-trofinetide-v1","contentSha256":"d51eeb35c1997e592559463a74e6f14cfd0a47d797ee80b75d55a55321a54af7"},{"objectId":"story:fda-drugs-nda217026:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA217026","domain":"Regulatory","dateInSource":"2023-03-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda217026/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#fda-drugs-nda217026-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#fda-drugs-nda217026-v1","contentSha256":"63e5c833f040625b2857928f63a3c2ac48576de8102ad634a35463e2850c46d1"},{"objectId":"story:fda-drugs-nda219884:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA219884","domain":"Regulatory","dateInSource":"2025-12-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda219884/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#fda-drugs-nda219884-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#fda-drugs-nda219884-v1","contentSha256":"909dc27392fa1c65e6f2e1e2aa32c29afc65adc0117b6d5c68f1f79eab6c8a22"},{"objectId":"story:federal-register-2023-06593:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2023-06593","domain":"Regulatory","dateInSource":"2023-03-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2023-06593/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#federal-register-2023-06593-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#federal-register-2023-06593-v1","contentSha256":"31a677c29f307bd2f5416fd5f58922a454b28436a058a7341e6085b690ccdeef"},{"objectId":"story:federal-register-2024-21941:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2024-21941","domain":"Regulatory","dateInSource":"2024-09-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2024-21941/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#federal-register-2024-21941-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#federal-register-2024-21941-v1","contentSha256":"4a1f2eb672a9a00f6f9e7afb8f83c90f810239a2abaa079f3e71213c828111d7"},{"objectId":"story:pubmed-pmid-37279541-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide.","domain":"Literature metadata","dateInSource":"2023-10-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37279541-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37279541-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-37279541-trofinetide-v1","contentSha256":"bc51c9d4d5cba7516478ab49af8f7f94fd99dd3c1d4783061accfa457399e5ee"},{"objectId":"story:pubmed-pmid-37291210-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.","domain":"Literature metadata","dateInSource":"2025-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37291210-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37291210-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-37291210-trofinetide-v1","contentSha256":"0e19eab293b315007e850c0ef29bf1b3fbec474d79f51459328e2d33ddd7d48f"},{"objectId":"story:pubmed-pmid-37460385-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide: a pioneering treatment for Rett syndrome.","domain":"Literature metadata","dateInSource":"2024-10-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37460385-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37460385-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-37460385-trofinetide-v1","contentSha256":"8bb76ad9f2bee2636d186583877ef1b637b7bea2594590b1c2bfc4488d94fa7a"},{"objectId":"story:pubmed-pmid-38035006-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide-a new chapter in rett syndrome's treatment.","domain":"Literature metadata","dateInSource":"2023-12-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38035006-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38035006-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38035006-trofinetide-v1","contentSha256":"f1d1797b4d7199e8d3e13cc897e03df67224fc80bb2726d718c562930a6232c9"},{"objectId":"story:pubmed-pmid-38318312-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Development of trofinetide for the treatment of Rett syndrome: from bench to bedside.","domain":"Literature metadata","dateInSource":"2024-10-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38318312-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38318312-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38318312-trofinetide-v1","contentSha256":"41775d5e588d22429b8589fd86a128119f3c6801d2b463b81814ae76343e64fa"},{"objectId":"story:pubmed-pmid-38378975-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.","domain":"Literature metadata","dateInSource":"2026-01-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38378975-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38378975-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38378975-trofinetide-v1","contentSha256":"34c11ed1cec2c7aa7231784bc0dcdbf7321b84ebf21fafbab16a4ba34d6cb8a2"},{"objectId":"story:pubmed-pmid-38555801-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Look at DAYBUE™ (Trofinetide) as first ever drug for treatment of Rett Syndrome.","domain":"Literature metadata","dateInSource":"2024-05-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38555801-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38555801-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38555801-trofinetide-v1","contentSha256":"1bcfaca1a1d8eb184916bde309eae216ddaa7644b565dc5dbc55c4bcae3086a9"},{"objectId":"story:pubmed-pmid-38869952-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome.","domain":"Literature metadata","dateInSource":"2024-07-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38869952-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38869952-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38869952-trofinetide-v1","contentSha256":"ce2abcbc7b5c19cf25ad3a163b0774b703b13b7d213e61ecec724561c28d42ad"},{"objectId":"story:pubmed-pmid-38981105-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide (Daybue) for Rett syndrome.","domain":"Literature metadata","dateInSource":"2024-07-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38981105-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38981105-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-38981105-trofinetide-v1","contentSha256":"f8f5b81fb1538cef789500a523811af4e35f1fea8bdf85970e3fd26b214895d2"},{"objectId":"story:pubmed-pmid-39395401-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Trofinetide treatment for Rett syndrome: Lessons to learn.","domain":"Literature metadata","dateInSource":"2026-06-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39395401-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39395401-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-39395401-trofinetide-v1","contentSha256":"cf6026c0f2953bc5fab2d827596f6962128d31f1f21785873f50533f0a434615"},{"objectId":"story:pubmed-pmid-39692837-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome.","domain":"Literature metadata","dateInSource":"2026-08-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39692837-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39692837-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-39692837-trofinetide-v1","contentSha256":"f779825aa52d1da68bd9f85a00f3041603d84319cc9b8de014c5f95e51dd4dc8"},{"objectId":"story:pubmed-pmid-39824747-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Assessing Experiences With Trofinetide for Rett Syndrome: Interviews With Caregivers of Participants in Clinical Trials.","domain":"Literature metadata","dateInSource":"2025-05-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39824747-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39824747-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-39824747-trofinetide-v1","contentSha256":"b238ce235071f5236b4ecb4e4e34ef9958ef1bdbefc946d98c5f62727f286868"},{"objectId":"story:pubmed-pmid-41850142-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy.","domain":"Literature metadata","dateInSource":"2026-07-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41850142-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-41850142-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-41850142-trofinetide-v1","contentSha256":"4392fd65e7cea10e537b8272ae34193a6321bd48442443089ad9abe898e7f9b8"},{"objectId":"story:pubmed-pmid-42083929-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Hydrophobic Tag-Assisted Scalable Synthesis of Trofinetide and Its GPE Analogues.","domain":"Literature metadata","dateInSource":"2026-07-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42083929-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42083929-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42083929-trofinetide-v1","contentSha256":"ea6620c35aadb8722e0de5628baba5e92715c01646d50fadd001ed14e4d924f5"},{"objectId":"story:pubmed-pmid-42287113-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Rett syndrome and real-world treatment patterns of trofinetide in the United States.","domain":"Literature metadata","dateInSource":"2026-06-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42287113-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42287113-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42287113-trofinetide-v1","contentSha256":"64cf48a769e8c6853ca0c9b2f2f9e2bac9b3157ed2b2102a90a4377eccd87cb6"},{"objectId":"story:pubmed-pmid-42294489-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States.","domain":"Literature metadata","dateInSource":"2026-09-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42294489-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42294489-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42294489-trofinetide-v1","contentSha256":"8f4f85b2dd09c5237a2e5538b2b0d94dee85796f1de08c0a5471cceea08c3465"},{"objectId":"story:pubmed-pmid-42377739-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.","domain":"Literature metadata","dateInSource":"2026-10-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42377739-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42377739-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42377739-trofinetide-v1","contentSha256":"c2bb095566ca4ac58c19dec50ca49bf4fda17baf622fa8ed53eb25777992f168"},{"objectId":"story:pubmed-pmid-42530159-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi-Stage Computational Analysis.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42530159-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42530159-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42530159-trofinetide-v1","contentSha256":"81d47cb02b91fd23c95433e94bb84cbda5b729c5827cf67afae17aa75685d3b9"},{"objectId":"story:pubmed-pmid-42563928-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Expert Consensus on Real-World Use of Trofinetide for Rett Syndrome Using a Modified Delphi Method.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42563928-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42563928-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42563928-trofinetide-v1","contentSha256":"bbb522545ff6ccb4d3a9d70011d4d668fb27c643e7fa34b8dd4dd13bb8a737bd"},{"objectId":"story:pubmed-pmid-42577214-trofinetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Characteristics of adult individuals with Rett syndrome treated or untreated with trofinetide in the United States.","domain":"Literature metadata","dateInSource":"2026-08-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42577214-trofinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42577214-trofinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/trofinetide.md#pubmed-pmid-42577214-trofinetide-v1","contentSha256":"d3f805b1368fdf8e177f32dad3e152fd49c177614f96db092734045368f4d274"}]}
